Hanson McClain Advisors »

Janux Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $978 26 37.65
2023-12-31 $600 56 10.73

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)

View all positions for Hanson McClain Advisors

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
Avidity Partners Management
Goldman Sachs Group
Samlyn Capital

View all funds holding Janux Therapeutics